Skip to main content

and
  1. Article

    Open Access

    BluePrint breast cancer molecular subty** recognizes single and dual subtype tumors with implications for therapeutic guidance

    BluePrint (BP) is an 80-gene molecular subty** test that classifies early-stage breast cancer (EBC) into Basal, Luminal, and HER2 subtypes. In most cases, breast tumors have one dominant subtype, representat...

    Midas M. Kuilman, Architha Ellappalayam in Breast Cancer Research and Treatment (2022)

  2. Article

    Open Access

    Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

    A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

    Krista Versteeg, Andrea R. Menicucci, Courtney Woolsey, Chad E. Mire in Scientific Reports (2019)

  3. Article

    Open Access

    Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

    Zaire Ebolavirus (ZEBOV) continues to pose a significant threat to human health as highlighted by the recent epidemic that originated in West Africa and the ongoing outbreak in the Democratic Rep...

    Krista Versteeg, Andrea R. Menicucci, Courtney Woolsey, Chad E. Mire in Scientific Reports (2017)

  4. Article

    Open Access

    Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection

    Ebola virus (EBOV) poses a significant threat to human health as highlighted by the recent epidemic in West Africa. Data from animal studies and a ring vaccination clinical trial conducted in Guinea during the...

    Andrea R. Menicucci, Suhas Sureshchandra, Andrea Marzi in Scientific Reports (2017)